Excelsior Medical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 10, 2022 at 03:35 pm EST
Share
Excelsior Medical Co., Ltd. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was TWD 1,841.14 million compared to TWD 1,575.78 million a year ago. Net income was TWD 201.63 million compared to TWD 167.86 million a year ago. Basic earnings per share from continuing operations was TWD 1.2952 compared to TWD 1.0762 a year ago. Diluted earnings per share from continuing operations was TWD 1.2952 compared to TWD 1.0762 a year ago.
For the nine months, sales was TWD 5,223.76 million compared to TWD 4,785.55 million a year ago. Net income was TWD 509.75 million compared to TWD 434.96 million a year ago. Basic earnings per share from continuing operations was TWD 3.2762 compared to TWD 2.7905 a year ago. Diluted earnings per share from continuing operations was TWD 3.2571 compared to TWD 2.781 a year ago.
EXCELSIOR MEDICAL CO., LTD. is a Taiwan-based company principally engaged in the distribution, maintenance and leasing of medical equipment and supplies. The Companyâs principal products include artificial kidneys, hemodialysis blood tubing sets and epidural needles, dialysis liquid medicines and powder medicines, dialysis machines, human erythropoietin, surgery consumable materials, blood bags, plasma replacement machines and beauty medical equipment, among others. The Company is also involved in the production and sales of self-owned soybean milk machines, as well as household air fresheners under the brand name of Coway. The Company mainly operates its businesses in domestic market and overseas markets.
EXCELSIOR MEDICAL CO., LTD. 